Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT

David Burns, Shabeeha Rana, Emma Martin, Sandeep Nagra, Janice Ward, Husam Osman, Andrew Bell, Paul Moss, Nigel H Russell, Charles Craddock, Christopher Fox, Sridhar Chaganti

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)
224 Downloads (Pure)
Filter
Finished

Search results